Patexia Research

Case number 1:23-cv-00327

Lawsuits

Bayer Intellectual Property GmbH et al v. Apotex Inc. et al > Summary

Court Case Number 1:23-cv-00327

Filing Date Mar 24, 2023

Termination Date Feb 27, 2024

Court Delaware District Court

Status Dismissed - Other

JudgesRichard G. Andrews

Plaintiff

4

Bayer Pharma Ag

JANSSEN PHARMACEUTICALS (Johnson & Johnson)

Bayer Intellectual Property Gmbh

Defendant

Defendant Attorneys

7

Apotex
Attorney Name: Brian J. Sodikoff

Apotex
Attorney Name: Kenneth L. Dorsney
Morris James LLP

Apotex
Attorney Name: Rachel L. Schweers

Apotex
Attorney Name: Brian J. Sodikoff

Apotex
Attorney Name: Kenneth L. Dorsney
Morris James LLP

Apotex
Attorney Name: Rachel L. Schweers

Attorney Name: Rachel L. Schweers

Counter Defendant

18

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell

JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell

Counter Claimant

4

Apotex
Attorney Name: Cortlan S. Hitch
Morris James LLP

Apotex
Attorney Name: Cortlan S. Hitch
Morris James LLP

Apotex
Attorney Name: Cortlan S. Hitch
Morris James LLP

Apotex
Attorney Name: Cortlan S. Hitch
Morris James LLP

Related Patents

Doc No	Title	Issue date
09539218	Prevention and treatment of thromboembolic disorders	Jan 10, 2017